iShares U.S. Healthcare ETF (IYH): outlook, holdings and fees
iShares U.S. Healthcare ETF (IYH) is an exchange-traded fund and is managed by iShares. The expense ratio is 0.39% and the yield is 1.16%. The ten largest holdings are 59% of the fund.
Fund data as of Oct 14, 2026 · Price Nov 2, 2026
ATLAS view on IYH
| Last price | $77.51 (-0.4%) |
|---|---|
| ATLAS chance of a higher price in 1 month | 54% |
| Likely 1-month range (50%) | $75.54 – $80.26 |
| Normal 1-day range (±1σ) | ±1.0% |
| Distribution yield | 1.16% |
ATLAS probabilities use the same calibrated model as every stock page. A fair value is shown for companies, not funds; the holdings below link to the fair value of each company.
IYH fund facts
| Issuer | iShares |
|---|---|
| Theme | Healthcare |
| Assets under management | $4.2B |
| Expense ratio | 0.39% |
| Number of holdings | 99 |
| Portfolio turnover | 3% |
| Inception | Jun 12, 2000 |
| Exchange | NYSE |
The fund generally will invest at least 80% of its assets in the component securities of its underlying index. The underlying index measures the performance of the healthcare sector of the U.S. equity market. The fund is non-diversified.
IYH top holdings
| Holding | Sector | Weight |
|---|---|---|
| Eli Lilly and Company LLY | Healthcare | 14.02% |
| Johnson & Johnson JNJ | Healthcare | 9.87% |
| AbbVie Inc ABBV | Healthcare | 7.93% |
| Merck & Company Inc MRK | Healthcare | 5.65% |
| UnitedHealth Group Incorporated UNH | Healthcare | 5.54% |
| Thermo Fisher Scientific Inc TMO | Healthcare | 3.95% |
| Amgen Inc AMGN | Healthcare | 3.55% |
| Gilead Sciences Inc GILD | Healthcare | 2.94% |
| Abbott Laboratories ABT | Healthcare | 2.67% |
| Pfizer Inc PFE | Healthcare | 2.53% |
Holdings with an ATLAS page link to their probability range, fair value and earnings calendar.
IYH sector breakdown
| Sector | Weight |
|---|---|
| Healthcare | 100.0% |
By region: North America 99.7%, United Kingdom 0.3%.
IYH returns and risk
| Year to date | +12.1% |
|---|---|
| 1 year | +19.9% |
| 3 years (annualised) | +11.2% |
| 5 years (annualised) | +6.9% |
| 10 years (annualised) | +10.4% |
| Volatility (3 years) | 14.0% |
| Sharpe ratio (3 years) | 0.48 |
Past returns do not guarantee future results.
IYH: frequently asked questions
What does IYH invest in?
iShares U.S. Healthcare ETF invests in a portfolio of securities. Its largest holdings are Eli Lilly and Company (14.0%), Johnson & Johnson (9.9%), AbbVie Inc (7.9%), Merck & Company Inc (5.7%), UnitedHealth Group Incorporated (5.5%).
What is the IYH expense ratio?
0.39% a year: about $39.00 for every $10,000 invested.
What is the IYH dividend yield?
1.16%. ATLAS does not hold the exact distribution dates for ETFs.
Will IYH go up?
Nobody can know. The ATLAS model puts the chance of a higher price in one month at 54%, with a likely range (50%) of $75.54 to $80.26 from $77.51 today. It is a probability, not a prediction.
How has IYH performed?
Year to date +12.1%, one year +19.9%, three years +11.2% a year, five years +6.9% a year. Past returns do not guarantee future results.
Similar ETFs: Healthcare
- State Street Health Care Select Sector SPDR ETF (XLV)
- Vanguard Health Care ETF (VHT)
- iShares Global Healthcare ETF (IXJ)
- iShares U.S. Medical Devices ETF (IHI)
- Fidelity MSCI Health Care Index ETF (FHLC)
- iShares U.S. Pharmaceuticals ETF (IHE)
- First Trust Health Care AlphaDEX Fund (FXH)
- First Trust Nasdaq Pharmaceuticals ETF (FTXH)
Educational information, not investment advice. Disclaimer